[Ocular consequences of systemic therapy].
D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D004977:Ethambutol / Q000009:adverse effects; D005128:Eye Diseases / Q000139:chemically induced*; D005901:Glaucoma / Q000139:chemically induced; D006801:Humans; D007980:Levodopa / Q000009:adverse effects; D009187:Myelitis / Q000139:chemically induced; D009902:Optic Neuritis / Q000139:chemically induced; D010640:Phenothiazines; D013577:Syndrome; D014801:Vitamin A / Q000009:adverse effects
D000893:Anti-Inflammatory Agents; D014150:Antipsychotic Agents; D010640:Phenothiazines; D014801:Vitamin A; D007980:Levodopa; D004977:Ethambutol
Les conséquences oculaires des thérapeutiques générales.